drugset / Trial / NCT00093249

Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)

NCT00093249 ↗

Phase 3 Completed 105 enrolled The Medicines Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy of clevidipine injection versus placebo in treating preoperative hypertension.

Timeline

Start
2004-01
Primary completion
2004-11
Completion
2004-11

Outcome

Met primary endpoint

paper significantly lower rate of treatment failure (7.5%, 4 of 53) than patients receiving placebo (82.7%, 43 of 52; P < 0.0001). PMID 17898366 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Clevidipine Small molecule — Intravenous

Indications